Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events new depth article explores future patient reported outcomes pros
… quality-of-life analyses Literature reviews Measurement of patient preferences for treatment options Observational studies Outcomes research strategy development Physician and payer … evaluation and implementation Treatment patterns and patient outcomes …
… analyses Literature reviews Meta-analysis studies Patient-reported outcomes (PRO) studies Payer research Psychometric …
… Thursday, January 31, 2019, 10 - 11am Watch the recording New Methods for Emerging Issues Network meta-analysis (NMA) … area of pharmaceutical and medical device research design. New meta-analysis methods are continually being developed to address new problems or to extend existing models. It is important to …
… ESRD could affect our ability to identify incident vaccine outcomes. Patients with ESRD frequently have in-center … serious. Some very clear patterns emerged. Some milder events had very clear spikes in incidence every 2 to 3 days, … occurring healthcare interactions. In contrast, severe events that required hospitalization didn't show clear …
Market Research We can collaborate with you to develop and support marketing strategies for your pharmaceutical products and/or devices. Our market research services include: Qualitative research (interviews and focus groups) with patients, physicians, …
… is to choose 20 drugs for IPAY 2029 and each year into the future. THE DRUG SELECTION PROCESS The DPN program focuses on … or other factors that are of importance to patients and patient-reported outcomes Changes to productivity, … determinations, passed in the US House in February 2024. New laws around the use of QALY alternatives may potentially …
… reviews Global Value Dossiers Meta-analysis studies Outcomes research strategy development Patient-reported outcomes (PRO) studies (including instrument …
… timing of treatment and immortal survival bias. Outcomes Our analyses of the registry data allowed our client to understand outcomes following first- and second-line therapy, identified …
… this International Society for Pharmacoeconomics and Outcomes Research (ISPOR) short course. Through presentation … current and projected treatment mix Estimating current and future drug costs Estimating change in disease-related costs … and presenting changes in annual budget impact and health outcomes Prerequisite: Knowledge and experience using …
Regulatory Guidance and Support We can support you throughout your regulatory negotiations. Our team has negotiated with the FDA’s Clinical Outcome Assessments (COA) team and a wide variety of reviewing divisions on numerous occasions to select and …